Hi Trommel,
Rule 3.1 requires continuous disclosure of material information: https://www.asx.com.au/documents/rules/Chapter03.pdf
Once an entity is or becomes aware of any information concerning it that a reasonable person would expect to have a material effect on the price or value of the entity’s securities, the entity must immediately tell ASX that information.
Rule 3.1A has an exception for incomplete negotiations.
I note that MNS says the term sheet has been 'signed' though, so unless your understanding is now that continuous disclosure does not apply because IM3 is only 47% owned by MNS then it would be difficult to my mind to reconcile this rule if you and I agree that the difference between a non-binding term sheet and a binding term sheet is material.
- Forums
- ASX - By Stock
- Ann: US$52M Term Sheet Signed for New York Battery Plant
Hi Trommel,Rule 3.1 requires continuous disclosure of material...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online